56 related articles for article (PubMed ID: 3319387)
1. Recurrent endometriosis.
Wheeler JM; Malinak LR
Contrib Gynecol Obstet; 1987; 16():13-21. PubMed ID: 3319387
[No Abstract] [Full Text] [Related]
2. Serum CA-125 levels in women with endometriosis.
Grover S; Koh H
Aust N Z J Obstet Gynaecol; 1990 Aug; 30(3):279-80. PubMed ID: 2256870
[No Abstract] [Full Text] [Related]
3. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
Reznikov IuP; Ul'ianov VI; Variukhin AS; Vanin AI; Vorontsova LP
Vopr Onkol; 1988; 34(1):51-6. PubMed ID: 3422524
[TBL] [Abstract][Full Text] [Related]
4. [Immunologic diagnosis of cancer--tumor markers].
Kawai T
Gan No Rinsho; 1989 Jan; Spec No():13-8. PubMed ID: 2915470
[No Abstract] [Full Text] [Related]
5. [Clinical significance of present tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865
[TBL] [Abstract][Full Text] [Related]
6. CA125 and endometriosis.
Umapathysivam K
Clin Reprod Fertil; 1987 Aug; 5(4):215-7. PubMed ID: 3482509
[No Abstract] [Full Text] [Related]
7. CA-125 and endometriosis.
Barbieri RL
Contrib Gynecol Obstet; 1987; 16():103-8. PubMed ID: 2446822
[No Abstract] [Full Text] [Related]
8. [Tumor markers in ovarian cancer].
Lahousen M
Jugosl Ginekol Perinatol; 1987; 27(3-4):73-5. PubMed ID: 3481005
[No Abstract] [Full Text] [Related]
9. [Incidence of CA 125 antigen in the blood of women with ovarian carcinoma].
Tosner J; Lacinová V; Louda B; Vanásek J
Cesk Gynekol; 1987 Nov; 52(9):681-4. PubMed ID: 3482173
[No Abstract] [Full Text] [Related]
10. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y
Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666
[TBL] [Abstract][Full Text] [Related]
11. [Tumor markers in the field of obstetrics and gynecology].
Mochizuki M
Rinsho Byori; 1986 Nov; 34(11):1274-83. PubMed ID: 3469446
[No Abstract] [Full Text] [Related]
12. [Tumor markers in human breast cancer].
Takami H; Shikata J
Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of tumor marker CA15-3 in breast cancer].
Kikuchi K; Uematsu Y; Takada Y; Kurihara E; Suito T; Fujisaki M; Takahashi R; Tamura T
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3095-100. PubMed ID: 3479052
[TBL] [Abstract][Full Text] [Related]
14. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
Ławicki S; Mroczko B; Szmitkowski M
Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
[TBL] [Abstract][Full Text] [Related]
15. [Tumor markers in gastrointestinal cancer and its clinical significance].
Taguchi T; Ota J; Sumida S; Rii M
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3004-9. PubMed ID: 3479051
[TBL] [Abstract][Full Text] [Related]
16. [Preclinical and clinical studies on a tumor marker, galactosyltransferase associated with tumor (GAT), in ovarian cancer (second report)--clinical significance of GAT and comparison with other tumor markers].
Nozawa S; Udagawa Y; Ito K; Susumu N; Sasaki H; Aoki D
Gan To Kagaku Ryoho; 1993 Feb; 20(2):279-85. PubMed ID: 8434967
[TBL] [Abstract][Full Text] [Related]
17. [Course of the serum determination of 4 tumor markers in viral hepatitis].
Coda C; Lanza E; Ciambellotti E; Cartia GL; Moro G
Minerva Med; 1987 Nov; 78(21):1577-81. PubMed ID: 3479707
[TBL] [Abstract][Full Text] [Related]
18. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary].
Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P
Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708
[No Abstract] [Full Text] [Related]
19. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
[TBL] [Abstract][Full Text] [Related]
20. [Studies on clinical usefulness of new tumor markers of ovarian cancer, CA54/61 and CA602--III. Measurement of serum samples from patients with various benign or malignant diseases].
Nozawa S; Udagawa Y; Sasaki H; Ito K; Akiya K; Terashima Y; Takamizawa H; Ohkura H; Fujimoto S; Hashimoto M
Gan To Kagaku Ryoho; 1994 May; 21(6):823-32. PubMed ID: 8185340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
